GlassScriptPhysician profile
Sandra H Sacks
NPI 1649513110
$6,619.07
in general payments reported to CMS, 2019-2025
21 companies · $2,601 in 2025
The $2,601 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2022: $1,458 · 2023: $590 · 2024: $906 · 2025: $2,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,171 · Consulting Fee: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,171.31 |
| Consulting Fee | $1,925.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,925.00 | 2025 | Fluid Systems - Research Devel, Fluid Systems - Infusion Systems |
| Boston Scientific Corporation | $819.83 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $745.78 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Synchromedii |
| Nalu Medical, INC. | $691.22 | 2022 | |
| Abbott Laboratories | $482.84 | 2019-2025 | Eterna, Proclaim |
| Nevro Corp. | $464.21 | 2019 | |
| Vertos Medical, INC. | $394.79 | 2022-2024 | Mild Device Kit |
| Painteq LLC | $256.90 | 2022 | |
| Si-Bone, INC. | $206.09 | 2024 | |
| Mml US, INC. | $171.04 | 2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $112.52 | 2019-2024 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $104.00 | 2025 | |
| Relievant Medsystems, INC. | $54.06 | 2022-2023 | Intracept |
| Stimwave Technologies Incorporated | $36.09 | 2019 | |
| Medtronic USA, INC. | $34.11 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $32.70 | 2025 | Prospera |
| Stryker Corporation | $20.73 | 2022 | |
| Piramal Critical Care | $20.25 | 2019 | |
| Glaxosmithkline, LLC. | $17.46 | 2023 | Trelegy Ellipta |
| West Therapeutics Development, LLC | $15.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Sacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.